Clinical Assessment of Visual Function With the Acrysof ReSTOR Multifocal IOL
NCT00758940 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL
Last updated 2015-05-12
Summary
An unmasked trial after bilateral implantation of AcrySof® ReSTOR®, SA60D3 IOL . Enrolled are at least 30 patients or as much as possible from the doctor's clinical practice perspective. 6 months follow-up after IOL implant in the 2nd eye
Conditions
- Visual Outcomes
Interventions
- DEVICE
-
Acrysof ReSTOR multifocal IOL
Implanted into the study eye following cataract extraction surgery
Sponsors & Collaborators
-
Alcon Research
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Contralateral ReSTOR / Monofocal or Phakic Eye
NCT00731640 ·Status: COMPLETED ·Phase: PHASE4
-
Visual Function Evaluation of Bilateral AcrySof ReSTOR Aspheric IOL
NCT00818116 ·Status: COMPLETED ·Phase: PHASE4
-
Visual Performance of Bilateral AcrySof ReSTOR Aspheric +4
NCT01215045 ·Status: COMPLETED
-
Retrospective / Prospective Clinical Study of AcrySof® IQ ReSTOR® +2.5 D Multifocal Toric Intraocular Lenses
NCT02176343 ·Status: COMPLETED ·Phase: NA
-
Visual Outcomes After Cataract Surgery: Multifocal AcrySof® IQ ReSTOR® Intraocular Lenses Versus Monofocal Intraocular Lenses
NCT01290068 ·Status: COMPLETED ·Phase: NA
-
A Clinical Outcome Study of Two Multifocal Intraocular Lenses (IOL) in Cataract Patients
NCT01684007 ·Status: COMPLETED ·Phase: NA
-
Pilot Study of AcrySof® IQ ReSTOR® +3.0 D Multifocal Toric Intraocular Lens (IOL)
NCT01200511 ·Status: COMPLETED ·Phase: NA
-
Visual Function and Patient Satisfaction After Bilateral Implantation of AcrySof Natural ReSTOR (Model SN60D3) or AcrySof Natural Monofocal (Model SN60AT)
NCT00759668 ·Status: COMPLETED ·Phase: NA
-
Clinical Investigation of AcrySof® IQ ReSTOR® +3.0 D Multifocal Toric Intraocular Lens (IOL)
NCT01424189 ·Status: COMPLETED ·Phase: NA
-
Clinical Investigation of AcrySof® IQ ReSTOR® +2.5 D Multifocal Intraocular Lens (IOL) Model SN6AD2 [SV25T0]
NCT01510717 ·Status: COMPLETED ·Phase: NA
-
Visual Function After Bilateral Implantation of AcrySof® Toric
NCT00758550 ·Status: COMPLETED ·Phase: PHASE4
-
Low Cylinder Toric
NCT00732030 ·Status: COMPLETED ·Phase: PHASE4
-
Visual Outcomes of Subjects Bilaterally Implanted With ReSTOR Aspheric +4 vs. Tecnis or Acri.LISA
NCT00721253 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of Visual Function After Bilateral Implantation of Presbyopia Correcting Intraocular Lenses
NCT01299155 ·Status: COMPLETED ·Phase: NA
-
Visual Function After Implantation of AcrySof® Toric Lens
NCT01074606 ·Status: TERMINATED ·Phase: PHASE4
-
ACRYSOF® ReSTOR® Aspheric +3.0 D Add Power Intraocular Lens (IOL)
NCT00684138 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of Visual Function After Bilateral Implantation of Presbyopia-Correcting Intraocular Lenses (IOLs)
NCT01257217 ·Status: COMPLETED ·Phase: NA
-
Surgeon Experience ReSTOR A +4 Intraocular Lens (IOL)
NCT00733512 ·Status: COMPLETED
-
AcrySof Toric Clinical Results
NCT01214863 ·Status: COMPLETED
-
Visual Outcome and Visual Quality After Bilateral Implantation of the AcrySof® IQ IOL Compared to MI60® and Tecnis® IOL
NCT00760058 ·Status: WITHDRAWN ·Phase: PHASE4
-
Presbyopia-Correcting Intraocular Lenses (IOLs)
NCT00963560 ·Status: COMPLETED ·Phase: PHASE4
-
Investigation of Corneal Aberrations and Visual Outcomes in Patients Implanted With an AcrySof Toric Intraocular Lens (IOL)
NCT00878839 ·Status: WITHDRAWN ·Phase: NA
-
Visual Function With Contralateral AcrySof® ReSTOR® Aspheric SN6AD1 and SN6AD3
NCT00710905 ·Status: TERMINATED ·Phase: PHASE4
-
A Comparison of Visual Function After Bilateral Implantation of Presbyopia-correcting Intraocular Lenses (IOLs)
NCT01166971 ·Status: COMPLETED ·Phase: PHASE4
-
Visual Function After Implantation of Bilateral AcrySof® Toric Natural Intraocular Lens
NCT00760487 ·Status: COMPLETED ·Phase: PHASE4